Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.
Antonelli L, Ardizzone D, Tachibana I, Adra N, Cary C, Hugar L, Sexton WJ, Bagrodia A, Mego M, Daneshmand S, Nicolai N, Nazzani S, Giannatempo P, Franza A, Heidenreich A, Paffenholz P, Saoud R, Eggener S, Ho M, Oswald N, Olson K, Tryakin A, Fedyanin M, Naoun N, Javaud C, Cazzaniga W, Nicol D, Gerdtsson A, Tandstad T, Fizazi K, Fankhauser CD; EAU-YAU Penile and Testis Cancer Working Group. Antonelli L, et al. Among authors: sexton wj. J Clin Oncol. 2023 Dec 1;41(34):5296-5305. doi: 10.1200/JCO.23.00443. Epub 2023 Sep 1. J Clin Oncol. 2023. PMID: 37656935
Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma.
Chakiryan NH, Jiang DD, Gillis KA, Green E, Hajiran A, Hugar L, Zemp L, Zhang J, Jain RK, Chahoud J, Spiess PE, Sexton W, Gilbert SM, Manley BJ. Chakiryan NH, et al. JAMA Netw Open. 2021 May 3;4(5):e2111329. doi: 10.1001/jamanetworkopen.2021.11329. JAMA Netw Open. 2021. PMID: 34032854 Free PMC article.
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility.
Fankhauser CD, Afferi L, Stroup SP, Rocco NR, Olson K, Bagrodia A, Baky F, Cazzaniga W, Mayer E, Nicol D, Islamoglu E, de Vergie S, Saoud R, Eggener SE, Nazzani S, Nicolai N, Hugar L, Sexton WJ, Matei DV, De Cobelli O, Cheaib J, Pierorazio PM, Porter J, Hermanns T, Hamilton RJ, Hiester A, Albers P, Clarke N, Mattei A. Fankhauser CD, et al. Among authors: sexton wj. World J Urol. 2022 Jun;40(6):1505-1512. doi: 10.1007/s00345-022-03974-9. Epub 2022 Mar 13. World J Urol. 2022. PMID: 35279732
Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes.
Woldu SL, Labbate C, Murray KS, Rose K, Sexton W, Tachibana I, Kaimakliotis H, Jacob J, Dickstein R, Linehan J, Nieder A, Bjurlin MA, Humphreys M, Ghodoussipour S, Quek ML, O'Donnell M, Eisner BH, Feldman AS, Matin SF, Lotan Y. Woldu SL, et al. Urol Oncol. 2023 Mar;41(3):147.e15-147.e21. doi: 10.1016/j.urolonc.2022.10.029. Epub 2022 Nov 22. Urol Oncol. 2023. PMID: 36424224
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour.
Antonelli L, Heidenreich A, Bagrodia A, Amini A, Baky F, Branger N, Cazzaniga W, Clinton TN, Daneshmand S, Djaladat H, Eggener S, Ghoreifi A, Hamilton RJ, Ho M, Sexton WJ, Nazzani S, Nicol D, Nicolai N, Olson K, Paffenholz P, Porter J, Qian Z, Rocco NR, Yerrapragada A, Stroup SP, Tachibana I, Terbuch A, Singla N, Cary C, Fankhauser CD; EAU‐YAU Penile and Testis Cancer Working Group. Antonelli L, et al. Among authors: sexton wj. BJU Int. 2024 Dec 11. doi: 10.1111/bju.16618. Online ahead of print. BJU Int. 2024. PMID: 39662898
Durability of response of UGN-101: Longitudinal follow up of multicenter study.
Woldu SL, Igel D, Johnson B, Murray KS, Miyagi H, Sexton W, Tachibana I, Kaimakliotis H, Jacob J, Dickstein R, Linehan J, Nieder A, Bjurlin MA, Heidenberg D, Humphreys M, Ghodoussipour S, Quek ML, O'Donnell M, Eisner BH, Matin SF, Feldman AS, Lotan Y. Woldu SL, et al. Urol Oncol. 2025 Jan 20:S1078-1439(24)01059-7. doi: 10.1016/j.urolonc.2024.12.279. Online ahead of print. Urol Oncol. 2025. PMID: 39837708
194 results